切换至 "中华医学电子期刊资源库"
高级检索
中华肺部疾病杂志(电子版)

中华肺部疾病杂志(电子版) ›› 2024, Vol. 17 ›› Issue (03) : 363 -367. doi: 10.3877/cma.j.issn.1674-6902.2024.03.004

论著

体外膜肺氧合救治急性呼吸窘迫综合征不良预后危险因素分析
魏丁1, 乔艳艳2, 顾兴3, 张燕2, 李艳燕2, 钱卫生2, 潘蕾2, 高永恒2,†(), 金发光2,†()   
  1. 1. 710032　西安，空军军医大学唐都医院呼吸与危重症医学科；046002　长治，长治市人民医院呼吸与危重症医学科
    2. 710032　西安，空军军医大学唐都医院呼吸与危重症医学科
    3. 710061　西安，西安市胸科医院呼吸与危重症医学科
  • 收稿日期:2024-03-29 出版日期:2024-06-25
  • 通信作者: 高永恒, 金发光
  • 基金资助:
    陕西省重点产业创新链（群）-社会发展领域(2022ZDLSF01-10)

Risk factors of poor prognosis after extracorporeal membrane oxygenation in acute respiratory distress syndrome patients

Ding Wei1, Yanyan Qiao2, Xing Gu3, Yan Zhang2, Yanyan Li2, Weisheng Qian2, Lei Pan2, Yongheng Gao2,†(), Faguang Jin2,†()   

  1. 1. Department of Respiratory and Critical Care Medicine, The Tangdu Hospital of Military Medical University, PLA Air Force, Xi′an 710032, China; Department of Respiratory and Critical Care Medicine, Changzhi People′s Hospital, Changzhi 046002, China
    2. Department of Respiratory and Critical Care Medicine, The Tangdu Hospital of Military Medical University, PLA Air Force, Xi′an 710032, China
    3. Department of Respiratory and Critical Care Medicine, Xi′an Chest Hospital, Xi′an 710061, China
  • Received:2024-03-29 Published:2024-06-25
  • Corresponding author: Yongheng Gao, Faguang Jin
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

魏丁, 乔艳艳, 顾兴, 张燕, 李艳燕, 钱卫生, 潘蕾, 高永恒, 金发光. 体外膜肺氧合救治急性呼吸窘迫综合征不良预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 363-367.

Ding Wei, Yanyan Qiao, Xing Gu, Yan Zhang, Yanyan Li, Weisheng Qian, Lei Pan, Yongheng Gao, Faguang Jin. Risk factors of poor prognosis after extracorporeal membrane oxygenation in acute respiratory distress syndrome patients[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(03): 363-367.

目的

分析体外膜肺氧合(extracorporeal membrane oxygenation, ECMO)辅助治疗急性呼吸窘迫综合征(acute respiratory distress syndrome, ARDS)预后不良的危险因素。

方法

选择2018年1月至2024年3月空军军医大学唐都医院呼吸与危重症团队管理诊断ARDS且接受ECMO救治的49例患者，收集临床资料，包括性别、年龄、平均动脉压、是否有基础疾病、呼气末正压通气(positive end-expiratory pressure, PEEP)、白细胞计数、血小板、肌酐、活化部分凝血活酶时间、丙氨酸氨基转移酶、C反应蛋白、白细胞介素-6(interleukin-6, IL-6)、降钙素原(procalcitonin, PCT)、ECMO上机时间、ECMO上机前气管插管时间、ARDS原发病、ARDS严重程度、ECMO相关并发症等参数，采用Logistic单因素及多因素回归分析ARDS患者ECMO救治中不良预后危险因素。

结果

ARDS生存者与死亡者相比，死亡者CRP升高[68.67 (40.82，113.92) vs. 19.78 (13.39，41.95)]，P<0.001，PCT升高[4.95 (2.44，7.31) vs. 1.57(0.23，3.97)]，P＝0.012，ECMO上机前气管插管时间延长[6(4，12) vs. 3(1，4)，P<0.001, ECMO相关并发症增多(32.7% vs. 14.3%)，P＝0.029。Logistic单因素回归分析显示，CRP(OR＝1.030，P＝0.003)、ECMO前气管插管天数(OR＝1.649，P＝0.005)及合并ECMO相关并发症(OR＝3.657，P＝0.033)与预后密切。Logistic多因素回归分析显示，ARDS基础疾病与ECMO救治中预后相关(OR＝5.128，95CI: 0.751～35.001)，P＝0.095。CRP、ECMO前气管插管时间及ECMO相关并发症与预后显著(OR＝1.043，95%CI：1.010～1.076，P＝0.01；OR＝1.691，95%CI：1.118～2.557，P＝0.013；OR＝9.482，95%CI：1.150～78.155，P＝0.037)。

结论

应用ECMO救治ARDS患者临床资料分析发现，CRP、ECMO前气管插管时间、ECMO并发症预测ARDS患者ECMO不良结局具有显著意义，早期识别和管理高危患者对提高生存率和救治成功率具有临床意义。

关键词: 急性呼吸窘迫综合征, 体外膜肺氧合, C反应蛋白, 降钙素原, 气管插管, 救治
Objective

To explore the risk factors of poor prognosis in patients with acute respiratory distress syndrome (ARDS) treated with extracorporeal membrane oxygenation (ECMO) as an adjuvant therapy.

Method

Clinical data of 49 patients diagnosed with ARDS and treated with ECMO from the Respiratory and Critical Care Team of Tangdu Hosptial of Air Force Military Medical University, during January 2018 to March 2024 were collected, including gender, age, Mean arterial pressure, presence of underlying disease, PEEP(positive end-expiratory pressure), white blood cell count, platelets, creatinine, activated partial thromboplastin time, alanine aminotransferase, C-reactive protein, interleukin-6(IL-6), procalcitonin (PCT), ECMO on machine time (days), and tracheal intubation time before ECMO (days), Primary disease of ARDS, Severity of ARDS, Complications related to ECMO patients. Logistic univariate and multivariate regression analysis were used to screen the risk factors of poor prognosis in ARDS patients treated with ECMO.

Result

Compared with patients in the survival group, patients in the death group had higher CRP levels (68.67[40.82, 113.92] vs. 19.78[13.39, 41.95], P<0.001), higher PCT levels (4.95[2.44, 7.31] vs. 1.57[0.23, 3.97], P=0.012), longer tracheal intubation time before ECMO (6[4, 12] vs. 3[1, 4], P<0.001), and more patients with ECMO related complications (32.7% vs. 14.3%, P=0.029), with statistically significant differences. Logistic univariate regression analysis showed that CRP (OR=1.030, P=0.003), days of tracheal intubation before ECMO (OR=1.649, P=0.005), and comorbidities related to ECMO (OR=3.657, P=0.033) were closely related to mortality prognosis, and the differences were statistically significant. Logistic multiple regression analysis showed that patients with underlying diseases were associated with ECMO mortality prognosis (OR=5.128, 95CI: 0.751~35.001), but the difference was not statistically significant (P=0.095). CRP levels, pre ECMO tracheal intubation time, and ECMO related complications were significantly correlated with mortality prognosis (OR=1.043, 95%CI: 1.010-1.076), P=0.01; OR=1.691, 95%CI: 1.118~2.557, P=0.013; OR=9.482, 95%CI: 1.150~78.155, P=0.037).

Key words: Acute respiratory distress syndrome, Extracorporeal membrane oxygenation, C-reactive protein, Procalcitonin, Tracheal intubation, Bring a patient out of danger
表1 ARDS患者一般临床资料[n(%)，(±s)]
临床资料 生存者 死亡者 P值
例数 23 26  
原发病     0.852
急性肺栓塞 1(2.0) 2(4.1)  
重症肺炎(病毒感染) 14(28.6) 13(26.5)  
重症肺炎(真菌感染) 2(4.1) 2(4.1)  
重症肺炎(细菌感染) 9(18.4) 6(12.2)  
性别     0.765
女 8(16.3) 8(16.3)  
男 15(30.6) 18(36.7)  
年龄 48.87±20.125 55.077±17.657 0.256
基础疾病     0.070
无 12(24.5) 7(14.3)  
有 11(22.4) 19(38.8)  
上机时长(d) 5.348±3.601 7.875±7.811 0.817
PEEP(mH2O) 9.5652±2.9669 9.6923±2.6649 0.875
MAP(mmHg) 81.478±19.79 84.077±16.317 0.617
氧合指数(mmHg) 77.217±42.190 67.000±22.035 0.936
ARDS严重程度     0.550
中度 4(8.2) 2(4.1)  
重度 19(38.8) 24(49.0)  
乳酸(mmol/L) 4.661±2.674 7.013±4.556 0.341
APTT(s) 44.052±38.272 36.800±31.053 0.645
ALT(g/L) 653.652±1 491.963 97.125±1 169.296 0.748
肌酐(μmol/L) 140.757±135.268 90.163±45.129 0.711
CRP(mg/L) 34.478±31.564 94.959±58.754 0.000
IL-6(pg/ml) 42.454±37.891 99.693±144.283 0.378
PCT(μg/ml) 3.384±4.777 6.086±5.643 0.012
WBC(×109/L) 16.138±15.755 12.034±5.458 0.787
PLT(×109) 138.870±80.905 150.063±86.970 0.141
上机前插管时间(d) 3.000±2.132 9.625±8.077 0.000
并发症     0.029
无 16(32.7) 10(20.4)  
有 7(14.3) 16(32.7)  
表2 ARDS患者Logistic回归分析
临床资料及特征 例数 单因素分析 多因素分析
OR(95%CI) P值 OR(95%CI) P值
PEEP 49 1.017(0.829～1.247) 0.872    
MAP 49 1.008(0.977～ 1.041) 0.609    
氧合指数 49 0.992(0.969 ～1.014) 0.466    
乳酸 49 1.128(0.938 ～1.357) 0.201    
年龄 49 1.018(0.987～1.050) 0.251    
PCT 49 1.121(0.965 ～1.301) 0.134    
基础疾病 30 2.961(0.899～9.750) 0.074 5.128(0.751～35.001) 0.095
CRP 49 1.030(1.010～1.050) 0.003 1.043(1.010～1.076) 0.010
上机前插管时间(d) 49 1.649(1.162～2.339) 0.005 1.691(1.118～2.557) 0.013
并发症 23 3.657(1.114～12.006) 0.033 9.482(1.150～78.155) 0.037
1
马李杰，李王平，金发光. 急性肺损伤/急性呼吸窘迫综合征发病机制的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(1): 65-68.
2
Gorman EA, O′Kane CM, McAuley DF. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management[J]. Lancet, 2022, 400(10358): 1157-1170.
3
Gattinoni L, Citerio G, Slutsky AS. Back to the future: ARDS guidelines, evidence, and opinions[J]. Intensive Care Med, 2023, 49 (10): 1226-1228.
4
Misset B, Piagnerelli M, Hoste E, et al. Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients[J]. N Engl J Med, 2023, 389(17): 1590-1600.
5
Roca O, Pacheco A, Garcia-de-Acilu M. To prone or not to prone ARDS patients on ECMO[J]. Crit Care, 2021, 25(1): 315.
6
金发光. 急性重症呼吸衰竭与体外膜肺氧合[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(1): 5-6.
7
Lucchini A, Gariboldi R, Villa M, et al. One hundred ECMO retrivals before and during the Covid-19 pandemic: an observational study[J]. Intensive Crit Care Nurs, 2023, 75: 103350.
8
Rambaud J, Broman LM, Chevret S, et al. Association between pediatric intensive care mortality and mechanical ventilation settings during extracorporeal membrane oxygenation for pediatric acute respiratory distress syndrome[J]. Eur J Pediatr, 2023, 182(10): 4487-4497.
9
Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome[J]. N Engl J Med, 2015, 372(8): 747-755.
10
Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I，Cavalcanti AB，Suzumura EA，et al. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs Low PEEP on mortality in patients with acute respiratory distress syndrome: A randomized clinical trial[J]. JAMA, 2017, 318(14): 1335-1345.
11
Gattinoni L, Tonetti T, Cressoni M, et al. Ventilator-related causes of lung injury: the mechanical power[J]. Intensive Care Med, 2016, 42(10): 1567-1575.
12
杜彦强，王　义，洪小杨. 体外膜肺氧合技术在儿科急性呼吸衰竭中的应用进展[J]. 中国临床新医学，2023, 16(7): 651-655.
13
Zou S, Liu J, Yang Z, et al. SAA and CRP are potential indicators in distinction and severity assessment for children with influenza[J]. Int J Infect Dis, 2021, 108: 357-362.
14
Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up[J]. Expert Rev Anti Infect Ther, 2021, 19(3): 345-357.
15
Fond G, Micoulaud-franchi JA, Faugere M, et al. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2020, 97: 109800.
16
Ngwa DN, Agrawal A. Structure-function relationships of C-reactive protein in bacterial infection[J]. Front Immunol, 2019, 10: 166.
17
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection[J]. Front Immunol, 2018, 9: 754.
18
Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19[J]. J Clin Virol, 2020, 127: 104370.
19
Tan TL, Kang CW, Ooi KS, et al. Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection[J]. Sci Rep, 2021, 11(1): 11369.
20
Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J]. N Engl J Med, 2018, 378(21): 1965-1975.
21
Gonzalez J, Benitez ID, de Gonzalo-Calvo D, et al. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study[J]. Crit Care, 2022, 26(1): 18.
22
Huber W, Findeisen M, Lahmer T, et al. Prediction of outcome in patients with ARDS: A prospective cohort study comparing ARDS-definitions and other ARDS-associated parameters, ratios and scores at intubation and over time[J]. PLoS One, 2020, 15(5): e0232720.
23
Supady A, Combes A, Barbaro RP, et al. Respiratory indications for ECMO: focus on COVID-19[J]. Intensive Care Med, 2022, 48(10): 1326-1337.
24
Schmidt M, Zogheib E, Roze H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J]. Intensive Care Med, 2013, 39 (10)：1704-1713.
25
Combes A, Brodie D, Bartlett R, et al. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients[J]. Am J Respir Crit Care Med, 2014, 190(5): 488-496.
[1] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[2] 杨茂宪, 沈鹏, 王倩倩, 吴旺, 沈永帅, 蒋禛, 徐龙生, 朱建刚, 刘倍倍. 吡啶甲酸镁联合地塞米松对急性呼吸窘迫综合征大鼠的治疗作用研究[J]. 中华危重症医学杂志(电子版), 2024, 17(03): 196-203.
[3] 中华医学会器官移植学分会. 体外膜肺氧合在遗体捐献供肾保护中的应用指南[J]. 中华移植杂志(电子版), 2024, 18(03): 148-158.
[4] 燕红玲, 王岩岩, 陈树斌. PCT、NLR联合LUBS预测ICU CRKP致呼吸机相关肺炎撤机及预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 617-620.
[5] 甘志新, 胡雍军, 肖晶, 胡明冬. 降钙素原在脓毒血症与肺部感染中的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 663-666.
[6] 李海亮, 俞云, 张星星, 陈管洁, 刘玲, 谢剑锋, 常炜. 经鼻高流量氧疗在危重症患者气管插管过程中效果的荟萃分析[J]. 中华重症医学电子杂志, 2024, 10(03): 227-235.
[7] 倪韫晖, 杨毅, 袁雪燕, 邱海波. 胸壁加压在急性呼吸窘迫综合征中的应用和临床进展[J]. 中华重症医学电子杂志, 2024, 10(03): 243-247.
[8] 杨永红, 杨莹, 齐红蕾, 刘福瑞, 朱金源. 单细胞测序在急性呼吸窘迫综合征中的应用进展[J]. 中华重症医学电子杂志, 2024, 10(03): 248-252.
[9] 李松栗, 黄蔚, 巢杰, 杨毅, 邱海波. 单核/巨噬细胞来源的细胞外囊泡在急性呼吸窘迫综合征中的研究进展[J]. 中华重症医学电子杂志, 2024, 10(03): 253-257.
[10] 田学, 谢晖, 王瑞兰. 急性呼吸窘迫综合征相关肺纤维化的研究进展[J]. 中华重症医学电子杂志, 2024, 10(03): 258-264.
[11] 许浩, 罗亮. 体外膜肺氧合支持期间新发感染的研究进展[J]. 中华重症医学电子杂志, 2024, 10(03): 292-297.
[12] 周帅, 张庆海, 王新, 马晓艳, 孙建霞, 王海波, 张继红. 静脉-动脉体外膜肺氧合辅助下溶栓治疗急性高危肺栓塞一例[J]. 中华重症医学电子杂志, 2024, 10(03): 298-302.
[13] 孙文恺, 沈青, 杭丽, 张迎春. 纤维蛋白原与清蛋白比值、中性粒细胞与白蛋白比值、C反应蛋白与溃疡性结肠炎病情评估和预后的关系[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 426-431.
[14] 张利远. 卫生应急院内救治"四八管理"研究应用[J]. 中华卫生应急电子杂志, 2024, 10(03): 192-192.
[15] 欧春影, 李晓宾, 郭靖, 许可, 王梦, 安晓雷. hs-CRP、Lp-PLA2和S100β与缺血性脑小血管病患者认知障碍的相关性[J]. 中华脑血管病杂志(电子版), 2024, 18(03): 265-269.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号